Investment Management of Virginia’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | $2.75M | Buy |
67,376
+240
| +0.4% | +$10.4K | 0.52% | 65 |
|
|
2022
Q4 | $3.44M | Sell |
67,136
-311
| -0.5% | -$14.9K | 0.67% | 52 |
|
|
2022
Q3 | $2.95M | Buy |
67,447
+430
| +0.6% | +$20.9K | 0.64% | 57 |
|
|
2022
Q2 | $3.51M | Sell |
67,017
-134
| -0.2% | -$6.83K | 0.72% | 47 |
|
|
2022
Q1 | $3.48M | Buy |
67,151
+3,131
| +5% | +$162K | 0.61% | 63 |
|
|
2021
Q4 | $3.78M | Sell |
64,020
-285
| -0.4% | -$14.1K | 0.61% | 55 |
|
|
2021
Q3 | $2.77M | Sell |
64,305
-2,561
| -4% | -$113K | 0.53% | 70 |
|
|
2021
Q2 | $2.62M | Sell |
66,866
-97
| -0.1% | -$3.77K | 0.5% | 72 |
|
|
2021
Q1 | $2.43M | Buy |
66,963
+915
| +1% | +$32.5K | 0.49% | 67 |
|
|
2020
Q4 | $2.43M | Sell |
66,048
-5,555
| -8% | -$204K | 0.53% | 66 |
|
|
2020
Q3 | $2.49M | Sell |
71,603
-7,194
| -9% | -$252K | 0.62% | 55 |
|
|
2020
Q2 | $2.44M | Buy |
78,797
+5,012
| +7% | +$170K | 0.61% | 60 |
|
|
2020
Q1 | $2.29M | Sell |
73,785
-4,625
| -6% | -$158K | 0.69% | 48 |
|
|
2019
Q4 | $2.92M | Sell |
78,410
-2,333
| -3% | -$83.1K | 0.67% | 47 |
|
|
2019
Q3 | $2.75M | Sell |
80,743
-1,881
| -2% | -$68.4K | 0.68% | 45 |
|
|
2019
Q2 | $3.4M | Sell |
82,624
-83,221
| -50% | -$3.3M | 0.81% | 43 |
|
|
2019
Q1 | $6.68M | Buy |
165,845
+82,430
| +99% | +$3.3M | 0.79% | 42 |
|
|
2018
Q4 | $3.45M | Sell |
83,415
-169
| -0.2% | -$7.02K | 0.9% | 35 |
|
|
2018
Q3 | $3.5M | Sell |
83,584
-37
| -0% | -$1.42K | 0.74% | 43 |
|
|
2018
Q2 | $2.88M | Buy |
83,621
+1,420
| +2% | +$48.5K | 0.63% | 52 |
|
|
2018
Q1 | $2.77M | Sell |
82,201
-469
| -0.6% | -$16.1K | 0.64% | 52 |
|
|
2017
Q4 | $2.84M | Sell |
82,670
-80
| -0.1% | -$2.73K | 0.67% | 50 |
|
|
2017
Q3 | $2.8M | Sell |
82,750
-230
| -0.3% | -$7.39K | 0.66% | 50 |
|
|
2017
Q2 | $2.65M | Buy |
82,980
+318
| +0.4% | +$10K | 0.64% | 53 |
|
|
2017
Q1 | $2.68M | Buy |
82,662
+13,526
| +20% | +$426K | 0.66% | 51 |
|
|
2016
Q4 | $2.13M | Buy |
69,136
+385
| +0.6% | +$11.8K | 0.51% | 62 |
|
|
2016
Q3 | $2.21M | Sell |
68,751
-939
| -1% | -$31.4K | 0.54% | 57 |
|
|
2016
Q2 | $2.33M | Buy |
69,690
+131
| +0.2% | +$4.18K | 0.6% | 58 |
|
|
2016
Q1 | $1.96M | Sell |
69,559
-1,159
| -2% | -$33.1K | 0.51% | 63 |
|
|
2015
Q4 | $2.17M | Sell |
70,718
-121
| -0.2% | -$3.81K | 0.58% | 61 |
|
|
2015
Q3 | $2.11M | Sell |
70,839
-991
| -1% | -$31.8K | 0.56% | 62 |
|
|
2015
Q2 | $2.29M | Sell |
71,830
-7,423
| -9% | -$242K | 0.53% | 64 |
|
|
2015
Q1 | $2.62M | Sell |
79,253
-2,040
| -3% | -$64.9K | 0.59% | 57 |
|
|
2014
Q4 | $2.4M | Sell |
81,293
-237
| -0.3% | -$6.8K | 0.5% | 69 |
|
|
2014
Q3 | $2.29M | Sell |
81,530
-343
| -0.4% | -$9.63K | 0.41% | 79 |
|
|
2014
Q2 | $2.31M | Sell |
81,873
-263
| -0.3% | -$7.5K | 0.37% | 82 |
|
|
2014
Q1 | $2.5M | Sell |
82,136
-1,824
| -2% | -$54.4K | 0.41% | 79 |
|
|
2013
Q4 | $2.44M | Sell |
83,960
-873
| -1% | -$25.4K | 0.4% | 75 |
|
|
2013
Q3 | $2.31M | Sell |
84,833
-502
| -0.6% | -$13.7K | 0.44% | 63 |
|
|
2013
Q2 | $2.27M | Buy |
+85,335
| New | +$2.36M | 0.5% | 57 |
|
Other funds holding PFE
Investment Management of Virginia's PFE Position: Q1 2023 in Review
Investment Management of Virginia increased its Pfizer (PFE) stake by 0.36% in Q1 2023, buying an estimated $10.4K and bringing the position to 67,376 shares worth $2.75M. The position accounts for 0.52% of the portfolio, ranked #65.
Investment Management of Virginia first reported a position in PFE in Q2 2013 and has held it in 40 quarters since. The position peaked at $6.68M in Q1 2019. 3,104 funds tracked by Wall St. Rank hold PFE as of Q1 2023.
- Investment Management of Virginia held 67,376 shares of Pfizer worth $2.75M as of Q1 2023.
- Investment Management of Virginia bought 240 Pfizer shares in Q1 2023, an estimated $10.4K.
- Pfizer made up 0.52% of Investment Management of Virginia's portfolio in Q1 2023, its #65 holding.
- Investment Management of Virginia first reported a position in Pfizer in Q2 2013 and has held it in 40 quarters since.
- Investment Management of Virginia's Pfizer position peaked at $6.68M in Q1 2019.
- 3,104 funds tracked by Wall St. Rank held Pfizer as of Q1 2023.
Based on Investment Management of Virginia's 13F filing for Q1 2023, filed 26 Apr 2023.